HPV 9 Vaccine
Human papillomavirus is a sexually transmitted infection caused by a group of viruses that can affect the skin, mouth, throat and genital area. There are over one hundred types and about 40 can affect the genital area. It is passed on if you have sex with a person already infected with HPV. This can be by vaginal, anal or oral sex. It can also be passed from a pregnant mother to her unborn baby.
Infection with some types of HPV can cause cancer of the cervix (neck of the womb) and can take years to develop after the initial infection with HPV. Around 3060 women are diagnosed with this type of cancer every year in the UK. 99% of cervical cancer is caused by HPV and of the high-risk types, HPV16 and HPV18 are responsible for more than two thirds of all cervical cancers globally. HPV6 and HPV11 cause the majority of cases of genital warts.
HPV is also a risk factor for other types of cancer, including:-
- Anal cancer
- Cancer of the penis
- Mouth and oropharyngeal cancers
Immunisation against HPV should dramatically reduce cervical cancer cases in the future and lead to fewer cases of genital warts. It may also reduce those cancers thought to be caused by HPV.
Even if you do not show any obvious symptoms, there is a very high chance that you can pass on the infection if you do not have treatment. If you are infected with HPV it is important that you are screened for other STIs.
|HPV 9 Vaccine||£190.00|
Wearing a condom during sex helps to reduce the risk of catching HPV, but does not eliminate it. Condoms do not cover the entire genital area and are often put on after sexual contact has begun, therefore a condom is no guarantee against the spread of HPV. The risk of infection increases with the number of changes of sexual partner.
Although most teenagers don't start having sex until after they're 16 years of age, it's important that they get this protection early enough and in good time — getting the vaccine as early as possible will protect them in the future. There are two HPV vaccines available in the UK and they are highly effective at preventing the infection of susceptible women with the HPV types covered by the vaccine.
Cervarix® is licensed for individuals from the age of 9 years but only protects against HPV16 and HPV18.
Gardasil® protects against four strains of HPV - HPV16, HPV18 and HPV6 and HPV11. This means that it also protects against genital warts as well as cervical cancer, as HPV 6 and 11 cause the majority of cases of genital warts.
In fact, Gardasil® is 99% effective at preventing genital warts. The national NHS immunisation programme provides vaccination for girls aged 11 to 18. At present, the national NHS immunisation programme does not provide vaccinations for girls younger than 9 or older than 18, nor does it provide vaccination to boys.
Since the immunisation programme began on a three-dose schedule, it has been established that a two-dose schedule is as effective as a course of three. From 2014, a two-dose schedule has been recommended, as long as vaccination is started before the patient's 15th birthday.
The three-dose schedule for teenagers over the age of 15 is as follows:
First dose: 0.5 ml given.
Second dose: 0.5 ml given at least one month after the first dose.
Third dose: 0.5 ml given at least three months after the second dose.
The two dose course for teenagers between the ages 11 and 13 years:
First dose: 0.5 ml given.
Second dose: 0.5 ml dose given 6-24 months after first dose.
There is no treatment for HPV. Most women who acquire HPV are able to clear the infection through their own immune system. Persistent presence of high-risk types of HPV can cause cervical lesions which, over time, may develop into cancer if untreated.